What's hot in animal biosafety?

ILAR Journal

Volumn 44, Issue 1, 2003, Pages 20-27

  Richmond, J Y ^a   Hill, R H ^a   Weyant, R S ^b   Nesby O'Dell, S L ^a   Vinson, P E ^c  

^a Office of Health and Safety   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Biosafety; Biosecurity; Infectious waste; Polio; Prions

Indexed keywords

CHEMICAL COMPOUND; POLIOMYELITIS VACCINE; TOXIN;

ANIMAL CARE; ARTHROPOD; ARTICLE; BIOLOGICAL WARFARE; BIOSAFETY; ENVIRONMENTAL PROTECTION; EXPERIMENTAL ANIMAL WELFARE; HUMAN; IMMUNIZATION; INFECTION RISK; LIVESTOCK; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; NONHUMAN; OCCUPATIONAL SAFETY; PATHOGENICITY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK MANAGEMENT; WILDLIFE;

ANIMALIA; ARTHROPODA; POLIOVIRUS;

EID: 0037216112     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.44.1.20     Document Type: Article

References (44)

1. Baron H, Pruisner SB. 2000. Prion diseases. In: Fleming DO, ed. Biological Safety Principles and Practices. Washington DC: ASM Press.
2. Benedict M. 2002. Rationale and summary of proposed arthropod containment guidelines (ACG). In: Richmond JY, ed. Proceedings of the 7th National Symposium on Biosafety: Managing Risk in Animal Care and Use. Atlanta: Eagleson Institute (www.eagleson.org).
3. Blattler T. 2002. Transmission of prion disease. APMIS 110:71-78.
4. CDC [Centers for Disease Control and Prevention]. 2001a. CDC update: Investigation of anthrax associated with intentional exposure and interim public health guidelines: October 2001. MMWR 50:889-897.
5. CDC [Centers for Disease Control and Prevention]. 2001b. Epidemic/Epizootic West Nile Virus in the United States: Revised Guidelines for Surveillance, Prevention, and Control. MMWR 50:273
6. Chin J, ed. 2000. Control of Communicable Diseases Manual. 17th ed. Washington DC: American Public Health Association.
7. Detrich R. 2002. Selection and use of ventilated caging systems for biohazard control. In: Richmond JY, ed. Proceedings of the 7th National Symposium on Biosafety: Managing Risk in Animal Care and Use. Atlanta: Eagleson Institute (www.eagleson.org).
8. Dowdle WR, Featherstone F, Kwe O, Oberste S, Pallanch MA, Sanders R. 2000. Working safely with wild poliovirus. In: Richmond JY, ed. Anthology of Biosafety. II. Facility Design Considerations. Mundelein IL: American Biological Safety Association.
9. Ernst DR, Race RE. 1993. Comparative analysis of scrapie agent inactivation. J Vir Methods 41:193-202.
10. Federal Register. 1996: 42 CFR Part 72 - Additional Requirements for Facilities Transferring or Receiving Select Agents: Final Rule, October 24, 1996, p 55190-55200.
11. Federal Register. 2002: 7 CFR Part 331 and 9 CFR Part 121 - Agricultural Bioterrorism Protection Act of 2002; Listing of Biological Agents and Toxins and Requirements and Procedures for Notification of Possession, August 12, 2002, p 52383-52389.
12. Fowler ME. 1995. Restraint and Handling of Wild and Domestic Animals. Ames: Iowa State University Press.
13. Fowler ME, Miller ER, eds. 1999. Zoo and Wild Animal Medicine: Current Therapy. Philadelphia: WB Saunders Co.
14. Horwich AL, Weissman JS. 1997. Deadly conformations - Protein misfolding in prion disease. Cell 89:499-510.
15. Hill RH, Gaunce JA, Whitehead P. 1999. Chemical safety levels (CSLs): A proposal for chemical safety practices in microbiological and biomedical laboratories. Chem Health Safety 6:6-14.
16. Hill RH, Hemphill ML, Richmond JY. 2001. Bioterrorism and select agent toxins. Chem Health Safety 8:30-35.
17. Hill RH. 2002. Ouch! Ouch! Ouch! That Hurts!! Chem Health Safety 9:42.
18. Johnson B, Royse C. 2002. Developing a biosecurity program. In: Richmond JY, ed. Proceedings of the 7th National Symposium on Biosafety: Managing Risk in Animal Care and Use. Atlanta: Eagleson Institute (www.eagleson.org).
19. Nolte KN, Taylor DG, Richmond JY. 2002. Bioisafety considerations for autopsy. Am J Forensic Med Pathol 23:107-122.
20. (http://www.cdc.gov/ncidod/dvbid/westnile/resources/ wnv-guidelines-apr-2001.pdf).
21. NRC [National Research Council]. 1995. Prudent Practices in the Laboratory: Handling and Disposal of Chemicals. Washington DC: National Academy Press.
22. NRC [National Research Council]. 1997. Occupational Health and Safety in the Care and Use of Research Animals. Washington DC: National Academy Press.
23. Pedersen NS, Smith E. 2002. Prion diseases: Epidemiology in man. APMIS 110:14-22.
24. Prusiner SB. 2001. Neurodegenerative diseases and prions, N Engl J Med 344:1516-1526.
25. PL [Public Law] 91-596. 1970. Occupational Safety and Health Act of 1970, Sections 5a and 5b. 91st Congress S. 2193, December 1970.
26. PL [Public Law] 107-56. 2002. The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2002. October 26, 2001.
27. PL [Public Law] 107-188. 2002. Public Health Security and Bioterrorism Preparedness and Response Act of 2002. June 12, 2002.
28. Richmond JY. 1996. Animal biosafety levels 1-4: An overview. In: Proceedings of the 4th National Symposium on Biosafety: Working Safely with Research Animals. Atlanta: Eagleson Institute (www.eagleson.org). p 5-8 and 168-192.
29. Richmond JY, ed. 2002a. Anthology of Biosafety, V. BSL-4 Laboratories. Mundelien IL: American Biological Safety Association (www.absa.org).
30. Richmond JY, ed. 2002b. Proceedings of the 7th National Symposium on Biosafety: Managing Risk in Animal Care and Use. Atlanta: Eagleson Institute (www.eagleson.org).
31. Richmond JY, McKinney RW, eds. 1999. Biosafety in Microbiological and Biomedical Laboratories. 4th ed. Washington DC: US DHHS.
32. Richmond JY, McKinney RW, eds. 2000. Primary Containment for Biohazards: Selection, Installation and Use of Biological Safety Cabinets. Washington DC: GPO.
33. Richmond JY, Quimby F. 1999. Considerations for Working Safely with Infectious Disease Agents in Research Animals, Handbook of Animal Models of Infection. New York: Academic Press.
34. Richmond JY, Ruble DL, Brown B, Jaax GP. 1997. Working safely at animal biosafety levels 3 and 4: Facility design and management implications. Lab Anim 26:28-35.
35. Strickland GT, ed. 2000. Hunter's Tropical Medicine and Emerging Infectious Diseases. 8th ed. Philadelphia: WB Saunders Co.
36. Tagochi F, Tamai Y, Uchida K, Kitajima R, Kojima H, Kawaguchi T, Ohtani Y, Miura A. 1991. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch Virol 119:297-301.
37. Taylor DM. 2000. Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J 159:10-17.
38. Taylor DM, Fernie K, Steele P. 1999. Boiling in sodium hydroxide inactivates mouse-passaged BSE agent. Abstracts of a Meeting of the Association of Veterinary Teachers and Research Workers, held March 29-31, 1999, in Scarborough UK. p 22.
39. Thomann WR. 2003. Chemical safety in animal care, use, and research. ILAR J 44:13-19.
40. Wilhelmsen CL, Jaax N, Davis K. 2002. Animal necropsy in maximum containment. In: Richmond JY, ed. Anthology of Biosafety, V. BSL-4 Laboratories. Mundelein IL: American Biological Safety Association (www.absa.org).
41. WHO [World Health Organization]. 1999a. WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. Geneva: WHO (www.who.int/emc).
42. WHO [World Health Organization]. 1999b. WHO Global Action Plan for Laboratory Containment of Wild Poliovirus. Geneva: WHO
43. WHO [World Health Organization]. 2002. Poliomyelitis: WHO Information Fact Sheet. April 2002. Geneva: WHO
44. WHO [World Health Organization]. 1993. Laboratory Biosafety Manual. 2nd ed. Geneva: WHO. RE